Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Nkarta Inc (NKTX)

Nkarta Inc (NKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nkarta Inc 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080 USA

www.nkartatx.com P: 925-407-1049

Description:

Nkarta Inc. is a biopharmaceutical company. It develops and commercializes cell therapies for cancer treatment. The company's product candidate includes NKX101 and NKX019, which are in clinical stage. Nkarta Inc. is based in South San Francisco, California.

Key Statistics

Overview:

Market Capitalization, $K 311,321
Enterprise Value, $K 280,281
Shares Outstanding, K 49,416
Annual Sales, $ 0 K
Annual Net Income, $ -117,500 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -27,750 K
EBIT, $ -131,650 K
EBITDA, $ -134,720 K
60-Month Beta 0.88
% of Insider Shareholders 5.60%
% of Institutional Shareholders 80.54%
Float, K 46,649
% Float 94.40%
Short Volume Ratio 0.18

Growth:

1-Year Return 33.55%
3-Year Return -77.47%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.57 on 03/21/24
Latest Earnings Date 05/09/24 [--]
Earnings Per Share ttm -2.40
EPS Growth vs. Prev Qtr -9.62%
EPS Growth vs. Prev Year 14.93%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

NKTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -38.07%
Return-on-Assets % -28.11%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.22
Book Value/Share 5.56
Interest Coverage -2.37
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar